NSC 207895

NSC 207895 is an inhibitor of MDMX and MDM2 used in studies of DNA Damage Response and Apoptosis and related signaling programs. In practice, this places the compound in experiments that measure checkpoint activation, DNA repair, and genome-stability control and caspase-associated cell-death signaling and survival decisions in apoptosis, cancer, and cell cycle models.

By inhibiting MDMX and MDM2, NSC 207895 can be used to examine checkpoint activation, DNA repair, and genome-stability control and caspase-associated cell-death signaling and survival decisions. This context is compatible with DNA-repair, checkpoint, and genotoxic-stress assays and apoptosis, viability, and caspase-readout assays, as well as transcriptional, biochemical, or phenotypic comparisons linked to the annotated pathway state. In apoptosis, cancer, and cell cycle models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.

Research Applications

• Target-focused assays involving MDMX and MDM2
• Pathway perturbation studies connected to DNA Damage Response and Apoptosis and related signaling programs
• Concentration-response inhibition and target-dependence studies
• Phenotypic profiling in apoptosis, cancer, and cell cycle models

Overall, NSC 207895 is appropriate when a defined chemical perturbant is needed to connect MDMX and MDM2 with measurable biochemical, transcriptional, electrophysiological, imaging, or phenotypic readouts in apoptosis, cancer, and cell cycle models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.